Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view

BACKGROUND: The aim of the present retrospective study was to analyze clinical outcome and risk factors associated with treatment outcomes according to KRAS status in patient with metastatic colorectal cancer (mCRC) treated with bevacizumab (bev) plus chemotherapy in the first-line setting. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bencsikova, Beatrix, Bortlicek, Zbynek, Halamkova, Jana, Ostrizkova, Lenka, Kiss, Igor, Melichar, Bohuslav, Pavlik, Tomas, Dusek, Ladislav, Valik, Dalibor, Vyzula, Rostislav, Zdrazilova-Dubska, Lenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376345/
https://www.ncbi.nlm.nih.gov/pubmed/25888291
http://dx.doi.org/10.1186/s12876-015-0266-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376345/
https://www.ncbi.nlm.nih.gov/pubmed/25888291
http://dx.doi.org/10.1186/s12876-015-0266-6

Ejemplares similares